TipRanks
Go Ultimate55% OFF

James Arthur Lavender Insider Profile

4 Followers

James Arthur Lavender, Director at BioMark Diagnostics, holds 5.25M shares in BioMark Diagnostics (Ticker: TSE:BUX). Most recently, James Arthur Lavender Bought 12,700 shares of BioMark Diagnostics on Jul 17, 2026 for an estimated value of C$6.99K.

James Arthur Lavender's Trading History

BUX
BioMark Diagnostics
Jul 17, 2026DirectorInformative Buy6.99KC$2.47M
TSE:BUX
Insider Shares: 5.25M (493.27%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jul 17, 2026Informative BuyC$6.99K12,700C$0.55――

You May Also Like

James Arthur Lavender insider profile FAQ

What stocks does James Arthur Lavender hold?
James Arthur Lavender holds: TSE:BUX stocks.
What was James Arthur Lavender’s latest transaction?
James Arthur Lavender’s latest transaction was an Informative Buy of C$6.99K.
What is James Arthur Lavender's role in BioMark Diagnostics?
James Arthur Lavender's role in BioMark Diagnostics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.